These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2785 related items for PubMed ID: 9988500

  • 41. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [Abstract] [Full Text] [Related]

  • 42. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P.
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [Abstract] [Full Text] [Related]

  • 43. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
    Pfaller MA, Messer SA, Jones RN, Castanheira M.
    J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
    [Abstract] [Full Text] [Related]

  • 44. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.
    Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, Peng Y.
    J Antimicrob Chemother; 2013 Apr; 68(4):778-85. PubMed ID: 23221625
    [Abstract] [Full Text] [Related]

  • 45. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S, Hofmann H.
    Mycoses; 1997 Apr; 40 Suppl 1():56-63. PubMed ID: 9417515
    [Abstract] [Full Text] [Related]

  • 46. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B, Teymuri M, Mahmoudi S, Valian SK, Movahedi Z, Eshaghi H, Mamishi S.
    Infect Disord Drug Targets; 2017 Apr; 17(3):178-184. PubMed ID: 28558643
    [Abstract] [Full Text] [Related]

  • 47. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G, Carrillo-Muñoz AJ, Arévalo MP, Salgado J, Alonso-Vargas R, Rodrigo JM, Ruesga MT, Valverde A, Pemán J, Cantón E, Martín-Mazuelos E, Pontón J.
    Chemotherapy; 2000 Apr; 46(6):395-401. PubMed ID: 11053905
    [Abstract] [Full Text] [Related]

  • 48. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F, Busso-Lopes AF, Lyra L, Peron IH, Taguchi H, Mikami Y, Kamei K, Moretti ML, Schreiber AZ.
    Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
    [Abstract] [Full Text] [Related]

  • 49. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
    Moran GP, Sanglard D, Donnelly SM, Shanley DB, Sullivan DJ, Coleman DC.
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1819-30. PubMed ID: 9661028
    [Abstract] [Full Text] [Related]

  • 50. Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Davey KG, Holmes AD, Johnson EM, Szekely A, Warnock DW.
    J Clin Microbiol; 1998 Apr; 36(4):926-30. PubMed ID: 9542910
    [Abstract] [Full Text] [Related]

  • 51. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G, Krupova Y, Lovaszova M, Roidova A, Trupl J, Liskova A, Hanzen J, Milosovic P, Lamosova M, Macekova L, Szovenyiova Z, Purgelova A, Obertik T, Bille J, Krcmery V.
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [Abstract] [Full Text] [Related]

  • 52. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
    Gohar AA, Badali H, Shokohi T, Nabili M, Amirrajab N, Moazeni M.
    Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
    [Abstract] [Full Text] [Related]

  • 53. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
    Wang Y, Liu JY, Shi C, Li WJ, Zhao Y, Yan L, Xiang MJ.
    Int J Antimicrob Agents; 2015 Nov; 46(5):552-9. PubMed ID: 26404130
    [Abstract] [Full Text] [Related]

  • 54. Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey.
    Rambach G, Oberhauser H, Speth C, Lass-Flörl C.
    Med Mycol; 2011 Nov; 49(8):856-63. PubMed ID: 21619497
    [Abstract] [Full Text] [Related]

  • 55. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
    Shen YZ, Lu HZ, Zhang YX.
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
    [Abstract] [Full Text] [Related]

  • 56. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P, Lapirattanakul J, Kaypetch R, Muadcheingka T.
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [Abstract] [Full Text] [Related]

  • 57. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA, Motley M, Warnock DW, Morrison CJ.
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [Abstract] [Full Text] [Related]

  • 58. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
    Basso LR, Gast CE, Bruzual I, Wong B.
    J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
    [Abstract] [Full Text] [Related]

  • 59. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD, Midgley J, Gazzard BG.
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [Abstract] [Full Text] [Related]

  • 60. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 140.